Compound ID | 155
Class: Antibiofilm agent (nitazoxanide derivative)
Spectrum of activity: | Gram-positive |
Details of activity: | Clostridium difficile infections (CDI) |
Propensity to select resistant mutants: | Yes |
Institute where first reported: | Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA |
Year first mentioned: | 2012 |
Highest developmental phase: | Preclinical |
Development status: | Active |
Chemical structure(s): | |||||||||||
|
|